BIOFIT Lille-France (29th Nov. – 1st Dec. 2016)
Oxeltis team will attend Biofit 2016 in Lille – France (29th Nov. – 1st Dec. 2016), and will be happy to meet you to discuss your current and future projects (...)
Auteur/autrice : oxeltis
XXII International Round Table on Nucleosides, Nucleotides and Nucleic Acids
Oxeltis will be happy to meet you at the International Round Table in Paris, July 18-22, 2016 to discuss your current and future projects involving nucleoside chemistry.Oxeltis is known for– (...)
Oxeltis at Bio International convention, San Francisco, USA
Oxeltis management team will be happy to meet you in San Francisco to discuss your current and future projects involving medicinal chemistry and custom synthesis.We look forward meeting you soon (...)
Oxeltis at meet2win, May 12-13, 2016, Bordeaux-FR
Oxeltis is at MEET2WIN, Oncology business convention in Bordeaux May 12-13. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L (...)
Oxeltis at ICAR, la Jolla – CA – April 17-21, 2016
Oxeltis team would be happy to meet you at the 29th International Conference on Antiviral Research (ICAR 2016, La Jolla (CA-USA), April 17-21, 2016), to discuss your current and future projects involving medicinal (...)
OXELTIS at Bio-Europe Spring (Stockholm April 4-6th, 2016)
Oxeltis will be present at BIO-Europe Spring (April 4-6th, 2016, Stockholm) We will be happy to meet you to discuss your current and future projects involving- medicinal chemistry (FTE contracts for Hit (...)
Medicinal Chemistry Strategy Meeting Europe, London 9 March 2016
Oxeltis will be present at Medicinal Chemistry Strategy Meeting Europe in London (UK). Looking forward meeting you there, contact@oxeltis.com
Toulouse Oncoweek (Feb 3-5, 2016)
Oxeltis will be present at OncoWeek in Toulouse (France). Looking forward meeting you there, contact@oxeltis.com
Oxeltis, Genepep and BCI-Pharma bring new nucleopeptide libraries to market
These multifunctional linear and macrocyclic peptides differ from the products already on the market, providing access to a new chemical space and new intellectual property Oxeltis, a medicinal chemistry and (...)
Oxeltis in the 2015 Deloitte In Extenso Technology Fast 50
Oxeltis ranked one of the fastest growing companies in the 2015 Deloitte In Extenso Technology Fast 50 Secured 30th position after a 559% revenue growth between 2011 and 2014, expects (...)